US pharmaceutical giant Pfizer on Tuesday announced a deal that it has signed
with an UN-backed group to allow its promising Covid-19 treatment to be made and
sold inexpensively in 95 poorer nations that are home to more than half of the
world
Found this useful? Share it with your team.
